Atlas Trials

A Study for Identification of Immune Determinants for Response to Nivolumab in Recurrent and/or Metastatic Head and Neck Squamous Cell Carcinoma

Clinical trial NCT04603248 · COMPLETED

Trial details

NCT number
NCT04603248
Sponsor
Yonsei University
Status
COMPLETED
Phase
Not Applicable
Study type
INTERVENTIONAL
Head and Neck Squamous Cell Carcinoma (HNSCC)
Start date
2020-12-03
Primary completion
2026-03-18
Enrollment
50

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.